Landmark gene therapy poised for US approval

Nature Reviews Drug Discovery 16, 739 (2017). doi:10.1038/nrd.2017.212 Author: Chris Morrison The FDA is weighing the fate of Spark Therapeutics' voretigene neparvovec, potentially the first among a wave of new gene therapies.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research